Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flinn

Showing results (821-830 of 1,038) with videos related to

Pageof 104
Sort By:
Frontiers in Public Health|May 27, 2025
Systematizing peer recovery support services for substance use disorder: a taxonomy for measuring recovery milestonesKimberly Horn, Ryan E Flinn, Angela Marie Hagaman, et al.
Journal of Animal Science|October 22, 2020
Maternal melatonin implants improve twin Merino lamb survivalTom Flinn, Jessica R Gunn, Karen L Kind, et al.
Frontiers in Immunology|March 6, 2023
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkersInes Bojanic, Nina Worel, Carolina P Pacini, et al.
JACC. Basic to Translational Science|January 14, 2026
Runx1 in Postn-Expressing Fibroblasts But Not Cardiomyocytes Exacerbates Adverse Cardiac Remodeling Post Myocardial InfarctionKaelin A Akins, Anooj Arkatkar, Michael A Flinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2007
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997Ian W Flinn, Donna S Neuberg, Michael R Grever, et al.
Oncogene|July 5, 2011
Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasisT Smirnova, Z N Zhou, R J Flinn, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)Ian W Flinn, Nancy L Bartlett, Kristie A Blum, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2013
Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignanciesDaryl Sonnichsen, David J Dorer, Jorge Cortes, et al.
BMJ Public Health|May 7, 2026
Proximity of city schools in Scotland to air quality monitors: an exploratory geomapping study in five Scottish citiesAlasdair McFadyen, Calum McPherson, Sarah Bartlett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's diseaseAnas Younes, Barbara Pro, Michael J Robertson, et al.
Pageof 104

Showing results (821-830 of 1,038) with videos related to

Sort By:
Pageof 104
Frontiers in Public Health|May 27, 2025
Systematizing peer recovery support services for substance use disorder: a taxonomy for measuring recovery milestonesKimberly Horn, Ryan E Flinn, Angela Marie Hagaman, et al.
Journal of Animal Science|October 22, 2020
Maternal melatonin implants improve twin Merino lamb survivalTom Flinn, Jessica R Gunn, Karen L Kind, et al.
Frontiers in Immunology|March 6, 2023
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkersInes Bojanic, Nina Worel, Carolina P Pacini, et al.
JACC. Basic to Translational Science|January 14, 2026
Runx1 in Postn-Expressing Fibroblasts But Not Cardiomyocytes Exacerbates Adverse Cardiac Remodeling Post Myocardial InfarctionKaelin A Akins, Anooj Arkatkar, Michael A Flinn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2007
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997Ian W Flinn, Donna S Neuberg, Michael R Grever, et al.
Oncogene|July 5, 2011
Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasisT Smirnova, Z N Zhou, R J Flinn, et al.
European Journal of Cancer (Oxford, England : 1990)|December 29, 2015
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)Ian W Flinn, Nancy L Bartlett, Kristie A Blum, et al.
Cancer Chemotherapy and Pharmacology|April 24, 2013
Analysis of the potential effect of ponatinib on the QTc interval in patients with refractory hematological malignanciesDaryl Sonnichsen, David J Dorer, Jorge Cortes, et al.
BMJ Public Health|May 7, 2026
Proximity of city schools in Scotland to air quality monitors: an exploratory geomapping study in five Scottish citiesAlasdair McFadyen, Calum McPherson, Sarah Bartlett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's diseaseAnas Younes, Barbara Pro, Michael J Robertson, et al.
Pageof 104